Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway

BACKGROUND: Side population (SP) cells, which have similar features to those of cancer stem cells, show resistance to dexamethasone (Dex) treatment. Thus, new drugs that can be used in combination with Dex to reduce the population of SP cells in multiple myeloma (MM) are required. Diallyl thiosulfin...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wenfeng, Fu, Yonghui, Zheng, Yongliang, Wang, Xiaoping, Liu, Bin, Zeng, Junquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866463/
https://www.ncbi.nlm.nih.gov/pubmed/33549034
http://dx.doi.org/10.1186/s12885-021-07833-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866463/
https://www.ncbi.nlm.nih.gov/pubmed/33549034
http://dx.doi.org/10.1186/s12885-021-07833-5

Ejemplares similares